CSS
ADVM

Cubist Systematic Strategies’s Adverum Biotechnologies ADVM Stock Holding History

Cubist Systematic Strategies’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,916
Closed -$4.12K – 2956
2025
Q2 		$4.12K Buy
+1,916
New +$5.36K ﹤0.01% 2859
2024
Q2 		– Sell
-8,483
Closed -$120K – 2887
2024
Q1 		$120K Buy
+8,483
New +$129K ﹤0.01% 3223
2023
Q4 		– Sell
-1,988
Closed -$29.8K – 3521
2023
Q3 		$29.8K Sell
1,988
-1,088
-35% -$19.5K ﹤0.01% 3067
2023
Q2 		$48.9K Sell
3,076
-75
-2% -$789 ﹤0.01% 3097
2023
Q1 		$22.6K Buy
+3,151
New +$22.3K ﹤0.01% 3663
2022
Q4 		– Sell
-1,438
Closed -$14K – 4197
2022
Q3 		$14K Sell
1,438
-293
-17% -$3.85K ﹤0.01% 4261
2022
Q2 		$21K Buy
1,731
+261
+18% +$2.73K ﹤0.01% 4213
2022
Q1 		$19K Sell
1,470
-5,142
-78% -$75.2K ﹤0.01% 3478
2021
Q4 		$116K Buy
6,612
+403
+6% +$8.07K ﹤0.01% 3168
2021
Q3 		$135K Sell
6,209
-2,087
-25% -$53.3K ﹤0.01% 2681
2021
Q2 		$290K Buy
8,296
+5,754
+226% +$310K ﹤0.01% 2354
2021
Q1 		$251K Buy
+2,542
New +$305K ﹤0.01% 2355
2020
Q4 		– Sell
-13,697
Closed -$1.41M – 2538
2020
Q3 		$1.41M Buy
+13,697
New +$2.05M 0.02% 1127
2020
Q2 		– Sell
-3,100
Closed -$303K – 2375
2020
Q1 		$303K Sell
3,100
-731
-19% -$85.2K 0.01% 1512
2019
Q4 		$441K Buy
+3,831
New +$338K 0.01% 1621
2019
Q1 		– Sell
-2,784
Closed -$88K – 2217
2018
Q4 		$88K Buy
+2,784
New +$113K ﹤0.01% 1782
2018
Q3 		– Sell
-1,353
Closed -$72K – 1859
2018
Q2 		$72K Sell
1,353
-3,172
-70% -$191K ﹤0.01% 1602
2018
Q1 		$262K Buy
+4,525
New +$282K 0.02% 1236

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Cubist Systematic Strategies's ADVM Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Adverum Biotechnologies (ADVM) in Q3 2025, closing a stake of 1,916 shares — an estimated $4.12K sold.

Cubist Systematic Strategies first reported a position in ADVM in Q1 2018 and held it in 18 quarters. The position peaked at $1.41M in Q3 2020. 50 funds tracked by Wall St. Rank hold ADVM as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Adverum Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,916 Adverum Biotechnologies shares in Q3 2025, an estimated $4.12K.
  • Cubist Systematic Strategies first reported a position in Adverum Biotechnologies in Q1 2018 and held it in 18 quarters.
  • Cubist Systematic Strategies's Adverum Biotechnologies position peaked at $1.41M in Q3 2020.
  • 50 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.